The APOE gene's three variants shape Alzheimer's risk differently
In short: A review of Alzheimer's disease research describes how the APOE gene, the strongest and most common genetic risk factor, affects more than half of all cases. The authors explain that its ε4 variant is linked to earlier and more abundant buildup of amyloid-beta plaques in the brain, while the ε2 variant appears protective compared with the common ε3 version.
The review draws together research on how the three APOE protein variants, which differ by just two amino acids, affect lipid transport and other brain processes beyond amyloid buildup. This complexity is one reason effective APOE-targeted treatments have been hard to design.
As a review, the paper synthesises existing studies rather than presenting new experiments, so its conclusions depend on the quality of that underlying research.
Why it matters: The APOE gene remains the best-understood genetic clue to why some people are more likely to develop Alzheimer's disease.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Source: Research: Raulin et al. (2022). ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies. Molecular Neurodegeneration. · cc-by
To cite this card, link to https://intellectplus.co.uk/app/health-research-the-apoe-gene-remains-the-most-significant-genetic-risk-fact.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Health · Latest · A–Z · All topics
